Patents by Inventor Baoxin XI

Baoxin XI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF
    Publication number: 20230145793
    Abstract: Provided is a substituted pyrimidine or pyridine amine derivative represented by formula (I), and a pharmaceutically acceptable salt, solvate, stereoisomer, prodrug, and pharmaceutical composition thereof, as well as medical application thereof. The derivative has significant adenosine A2A receptor and/or adenosine A2B receptor antagonistic activities.
    Type: Application
    Filed: March 16, 2021
    Publication date: May 11, 2023
    Applicants: SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD., YANGTZE RIVER PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Lifeng LIU, Zhiming ZHAO, Feng XU, Hailong WANG, Baoxin XI, Zhongan TONG, Huiping GUAN
  • Pyridylamino substituted heterotricyclic compounds, and preparation method and pharmaceutical use thereof
    Patent number: 11168088
    Abstract: The present disclosure relates to pyridinamine-substituted heterotricyclo compounds, a preparation method thereof, and a use thereof in medicines. Specifically, a compound of formula (I), or a pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug thereof, a preparation method and a use thereof are disclosed, wherein the groups in the formula (I) are as defined in the Description and claims.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: November 9, 2021
    Inventors: Yang Liu, Jiangwei Wang, Qing Zhang, Yonggang Chen, Baoxin Xi, Wangbin Sun, Yingtao Liu, Xi Chen
  • PYRIDYLAMINO SUBSTITUTED HETEROTRICYCLIC COMPOUNDS, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF
    Publication number: 20200039983
    Abstract: The present disclosure relates to pyridinamine-substituted heterotricyclo compounds, a preparation method thereof, and a use thereof in medicines. Specifically, a compound of formula (I), or a pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug thereof, a preparation method and a use thereof are disclosed, wherein the groups in the formula (I) are as defined in the Description and claims.
    Type: Application
    Filed: November 10, 2017
    Publication date: February 6, 2020
    Inventors: Yang LIU, Jiangwei WANG, Qing ZHANG, Yonggang CHEN, Baoxin XI, Wangbin SUN, Yingtao LIU, Xi CHEN